SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-005924
Filing Date
2014-08-14
Accepted
2014-08-14 16:57:46
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0614_biopharmxcorp.htm 10-Q 304981
2 CERTIFICATION f10q0614ex31i_biopharmx.htm EX-31.1 11479
3 CERTIFICATION f10q0614ex32i_biopharmx.htm EX-32.1 3908
  Complete submission text file 0001213900-14-005924.txt   2506848

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bpmx-20140630.xml EX-101.INS 253715
5 XBRL SCHEMA FILE bpmx-20140630.xsd EX-101.SCH 25533
6 XBRL CALCULATION FILE bpmx-20140630_cal.xml EX-101.CAL 27340
7 XBRL DEFINITION FILE bpmx-20140630_def.xml EX-101.DEF 77936
8 XBRL LABEL FILE bpmx-20140630_lab.xml EX-101.LAB 227711
9 XBRL PRESENTATION FILE bpmx-20140630_pre.xml EX-101.PRE 161208
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54871 | Film No.: 141043927
SIC: 1700 Construction - Special Trade Contractors